Have a personal or library account? Click to login
Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion Cover

Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion

Radiology and Oncology
Volume 55 (2021): Issue 3 (September 2021)
By: Johannes M. Ludwig,  Johannes Haubold,  Sebastian Bauer,  Heike Richly,  Jens T. Siveke,  Julia Wimmer,  Lale Umutlu,  Benedikt M. Schaarschmidt and  Jens M. Theysohn  
Open Access
|May 2021

Metrics

DOI: https://doi.org/10.2478/raon-2021-0027 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 347 - 353
Submitted on: Jan 17, 2021
|
Accepted on: Apr 12, 2021
|
Published on: May 31, 2021
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
uveal melanoma,
liver metastases,
transarterial hepatic chemoperfusion,
melphalan,
inflammatory markers
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2021 Johannes M. Ludwig, Johannes Haubold, Sebastian Bauer, Heike Richly, Jens T. Siveke, Julia Wimmer, Lale Umutlu, Benedikt M. Schaarschmidt, Jens M. Theysohn, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 55 (2021): Issue 3 (September 2021)Next article